IUPAC/Chemical Name
(4R,5R,9aR,9a1R,14S,14aS,Z)-7-ethylidene-4,14-dihydroxy-4,5-dimethyldodecahydro-[1,6]dioxacyclododecino[2,3,4-gh]pyrrolizine-3,8-dione
InChi Key
YEXVXKIMPBHRQR-VFQWDWSUSA-N
InChi Code
InChI=1S/C18H27NO6/c1-4-11-7-10(2)18(3,23)17(22)24-9-12-13(20)8-19-6-5-14(15(12)19)25-16(11)21/h4,10,12-15,20,23H,5-9H2,1-3H3/b11-4-/t10-,12+,13-,14-,15-,18-/m1/s1
SMILES Code
[H][C@@]12[C@]([H])(OC(/C(C[C@H]([C@]3(O)C)C)=C\C)=O)CCN1C[C@@H](O)[C@]2([H])COC3=O
Purity
>98% (or refer to the Certificate of Analysis)
Shipping Condition
Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
Storage Condition
Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).
Solubility
Soluble in DMSO
Shelf Life
>3 years if stored properly
Drug Formulation
This drug may be formulated in DMSO
Stock Solution Storage
0 - 4 C for short term (days to weeks), or -20 C for long term (months).
HS Tariff Code
2934.99.03.00
Preparing Stock Solutions
The following data is based on the
product
molecular weight
353.41
Batch specific molecular weights may vary
from batch to batch
due to the degree of hydration, which will
affect the solvent
volumes required to prepare stock solutions.
Concentration / Solvent Volume / Mass |
1 mg |
5 mg |
10 mg |
1 mM |
1.15 mL |
5.76 mL |
11.51 mL |
5 mM |
0.23 mL |
1.15 mL |
2.3 mL |
10 mM |
0.12 mL |
0.58 mL |
1.15 mL |
50 mM |
0.02 mL |
0.12 mL |
0.23 mL |
1: Castells E, Mulder PP, Pérez-Trujillo M. Diversity of pyrrolizidine alkaloids in native and invasive Senecio pterophorus (Asteraceae): implications for toxicity. Phytochemistry. 2014 Dec;108:137-46. doi: 10.1016/j.phytochem.2014.09.006. Epub 2014 Sep 27. PubMed PMID: 25269662.
2: Nieto-Alvarez DA, Calderón JS, Mancilla T. Synthesis of (1R,2R,7R,7aS)-1-hydroxymethyl-2,3,5,6,7,7a-hexahydropyrrolizidine-1,2,7-triol from rosmarinine degradation. Nat Prod Res. 2003 Jan;17(1):33-6. PubMed PMID: 12674140.
3: Styles J, Ashby J, Mattocks AR. Evaluation in vitro of several pyrrolizidine alkaloid carcinogens: observations on the essential pyrrolic nucleus. Carcinogenesis. 1980 Feb;1(2):161-4. PubMed PMID: 22282996.
4: Zündorf I, Wiedenfeld H, Röder E, Dingermann T. Generation and characterization of monoclonal antibodies against the pyrrolizidine alkaloid retrorsine. Planta Med. 1998 Apr;64(3):259-63. PubMed PMID: 9581524.